HIMSS16 Presentations Highlight Role of Wolters Kluwer Clinical Drug Information Solution in Reducing Medication Errors, Minimizing Alert Fatigue

Date: 
Thursday, February 18, 2016

February 18, 2016 – The Health division of Wolters Kluwer, a leading global provider of information and point of care solutions for the healthcare industry, announced today that two presentations during the HIMSS16 Conference & Exhibition will explore the impact of its Clinical Drug Information drug data solution Medi-Span® on medication errors and alert fatigue. The presentations will showcase how Group Health Cooperative South Central Wisconsin (GHC-SCW) and MetroHealth Systems used the drug data and medication decision support solution to reduce nuisance alerts and physician overrides as well as optimize drug-dose decision support to prevent clinically significant prescribing errors.

GHC-SCW Formulary Pharmacist Michael Ochowski, R.Ph., and IT Team Lead-Interoperability Philip Boll will provide an in-depth look at the 2015 initiative undertaken by the non-profit health plan, consisting of 82,000 members and five primary care clinics, to reduce nuisance alerts and improve the organization’s override rate, which stood at more than 95%. By filtering alerts based on clinical staff input and clinical metrics built in part from Medi-Span severity classifications, supporting evidence and significance scores, GHC-SCW reduced the overall number of alerts per 100 orders by nearly half and achieved a decline in override rates. Distribution of alerts also improved, with pharmacy managing two-thirds of the load, significantly reducing the burden on physicians.

“Alert Fatigue: Improving Alert Impact by Reducing Noise” takes place on March 2 at 4 p.m. PST, in Palazzo G in the Sands Expo Convention Center in Las Vegas.

MetroHealth System CMIO and Vice President of Health Informatics David Kaelber, MD, PhD, MPH, who is board-certified in clinical informatics, will walk attendees through the Cleveland, Ohio-based health system’s approach to optimizing drug-dose clinical decision support (CDS) to prevent clinically significant errors from occurring within the estimated 3.4 million prescriptions its physicians order annually. Leveraging Medi-Span to help optimize sensitivity and specificity drove an 80% reduction in alerts without impacting those that are clinically significant. Alerts now fire on just 3% of orders at MetroHealth, which received the HIMSS Analytics EMRAM Stage 7 Ambulatory award in 2014 and is a 2015 HIMSS Enterprise Davies Award recipient.

“Optimizing Drug-Dose Checking to Minimize Alert Fatigue” takes place on March 4 at Noon PST in Lando 4205 in the convention center.

“Implementation of evidence-based medication decision support impacts patient safety by improving adherence to generally accepted standards based on patient-specific information. However, these outcomes cannot be fully achieved if attention is not paid to alert fatigue,” said Denise Basow, MD, President & CEO of Clinical Effectiveness at Wolters Kluwer. “The Medi-Span solution streamlines valuable content and decision support functionality into customizable, intelligent databases and integrated tools that help reduce alert fatigue by maximizing sensitivity and specificity to produce more clinically-significant alerts.”

Wolters Kluwer will feature its full suite of Clinical Drug Information solutions in Booth #5537 at HIMSS16, which takes place February 29 through March 4 at the Sands Expo Convention Center in Las Vegas.

About Wolters Kluwer
Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.

Wolters Kluwer reported 2014 annual revenues of €3.7 billion. The group serves customers in over 170 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visit http://www.wolterskluwer.com/, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.

Media
Meagan McCord
Manager, Marketing Communications
Wolters Kluwer | Clinical Drug Information
330-650-6506
meagan.mccord@wolterskluwer.com